Breaking News, Collaborations & Alliances

IVT, Dalton Scale Up Vax Platform

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ImmunoVaccine Technologies Inc. (IVT) has successfully scaled-up the manufacturing process for its vaccine platform, Vaccimax. The manufacturing development was performed by Dalton Pharma Services. VacciMax is a vaccine-enhancement platform comprised of a special emulsion of liposomes, antigens, adjuvants and oil, according to IVT. To prepare VacciMax for human cancer clinical trials, IVT has been developing its platform to meet all regulatory requirements, including manufacturing in a GMP se...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters